Filing Details
- Accession Number:
- 0001062993-23-012051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-24 16:32:59
- Reporting Period:
- 2023-05-22
- Accepted Time:
- 2023-05-24 16:32:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1603454 | Celcuity Inc. | CELC | Services-Medical Laboratories (8071) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775749 | Leo Furcht | 16305 36Th Avenue North Suite 100 Minneapolis MN 55446 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-22 | 10,000 | $10.32 | 10,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $1.60 | 2023-12-14 | 250 | 250 | Direct | |
| Common Stock | Stock Option (right to buy) | $3.60 | 2024-12-14 | 250 | 250 | Direct | |
| Common Stock | Stock Option (right to buy) | $7.60 | 2025-12-14 | 250 | 250 | Direct | |
| Common Stock | Stock Option (right to buy) | $7.60 | 2026-12-14 | 250 | 250 | Direct | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2027-12-29 | 500 | 500 | Direct | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2028-12-31 | 500 | 500 | Direct | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2029-05-16 | 5,054 | 5,054 | Direct | |
| Common Stock | Stock Option (right to buy) | $5.10 | 2030-05-14 | 25,308 | 25,308 | Direct | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2031-05-12 | 4,619 | 4,619 | Direct | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2032-05-17 | 24,449 | 24,449 | Direct | |
| Common Stock | Stock Option (right to buy) | $9.58 | 2033-05-15 | 11,645 | 11,645 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-12-14 | 250 | 250 | Direct |
| 2024-12-14 | 250 | 250 | Direct |
| 2025-12-14 | 250 | 250 | Direct |
| 2026-12-14 | 250 | 250 | Direct |
| 2027-12-29 | 500 | 500 | Direct |
| 2028-12-31 | 500 | 500 | Direct |
| 2029-05-16 | 5,054 | 5,054 | Direct |
| 2030-05-14 | 25,308 | 25,308 | Direct |
| 2031-05-12 | 4,619 | 4,619 | Direct |
| 2032-05-17 | 24,449 | 24,449 | Direct |
| 2033-05-15 | 11,645 | 11,645 | Direct |
Footnotes
- Fully vested.
- This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.
Billionaire Hedge Funds
